<SEC-DOCUMENT>0001004878-14-000303-index.html : 20140819
<SEC-HEADER>0001004878-14-000303.hdr.sgml : 20140819
<ACCEPTANCE-DATETIME>20140819174102
ACCESSION NUMBER:		0001004878-14-000303
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		6
FILED AS OF DATE:		20140819
DATE AS OF CHANGE:		20140819
EFFECTIVENESS DATE:		20140819

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CEL SCI CORP
		CENTRAL INDEX KEY:			0000725363
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				840916344
		STATE OF INCORPORATION:			CO
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-198244
		FILM NUMBER:		141053241

	BUSINESS ADDRESS:	
		STREET 1:		8229 BOONE BLVD .
		STREET 2:		SUITE 802
		CITY:			VIENNA
		STATE:			VA
		ZIP:			22182
		BUSINESS PHONE:		7035069460

	MAIL ADDRESS:	
		STREET 1:		8229 BOONE BLVD.
		STREET 2:		SUITE 802
		CITY:			VIENNA
		STATE:			VA
		ZIP:			22182

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INTERLEUKIN 2 INC
		DATE OF NAME CHANGE:	19880317
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>s8aug-14.txt
<DESCRIPTION>S-8 AUG. 2014
<TEXT>
Document 1 - file: s8aug-14.txt

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4
<SEQUENCE>2
<FILENAME>s8exh4baug-14.txt
<DESCRIPTION>EXH, 4(B) - 2013 NON-QUAL. STOK OPION PLAN
<TEXT>
Document 2 - file: s8exh4baug-14.txt

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5
<SEQUENCE>3
<FILENAME>s8exh5aug-14.txt
<DESCRIPTION>EXH. 5 - LEGAL OPINION
<TEXT>
Document 3 - file: s8exh5aug-14.txt

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23
<SEQUENCE>4
<FILENAME>s8exh231aug-14.txt
<DESCRIPTION>EXH 23.1 - CONSENT OF ATTORNEY
<TEXT>
Document 4 - file: s8exh231aug-14.txt

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23
<SEQUENCE>5
<FILENAME>s8exh232aug-14.txt
<DESCRIPTION>EXH.23.2 - CONSENT OF ACCOUNTANT
<TEXT>
Document 5 - file: s8exh232aug-14.txt

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>6
<FILENAME>s8exh99aug-14.txt
<DESCRIPTION>EXH. 99 - RE-OFFER PROSPECTUS
<TEXT>
Document 6 - file: s8exh99aug-14.txt

</DOCUMENT>
</SEC-DOCUMENT>